AnalystsDaniel MarkowitzDaniel Markowitz's Stock Forecasts
AnalystsDaniel Markowitz
Analyst Ranking
Bottom 7%
#4939 out of 5277 analysts
Average Return
-5.75%
Win Rate
42%13 out of 31
Risk vs Reward
Poor
Good
Daniel Markowitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Guardant Health IncGH | +60.58% | $63.44 | $101.87 | 2025-10-06 - 2026-01-05 | Buy |
Natera IncNTRA | +41.54% | $138.00 | $195.32 | 2025-07-27 - 2026-05-13 | Buy |
Rambus IncRMBS | +38.95% | $97.05 | $134.85 | 2025-09-15 - 2026-05-13 | Buy |
Rambus IncRMBS | +36.97% | $98.45 | $134.85 | 2026-02-02 - 2026-05-13 | Buy |
West Pharmaceutical Services IncWST | +30.94% | $230.95 | $302.40 | 2026-02-02 - 2026-05-13 | Buy |
Daniel Markowitz Analyst Color
Get additional color on Daniel Markowitz's coverage of popular stocks
Daniel Markowitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Natera IncNTRA | 4 | Buy | $270.00 | +38.23% | Maintains | 7 days ago |
Guardant Health IncGH | 6 | Hold | $95.00 | -3.52% | Maintains | 7 days ago |
Bio Techne CorpTECH | 6 | Hold | $50.00 | +11.38% | Maintains | 8 days ago |
Insulet CorpPODD | 3 | Buy | $200.00 | +34.37% | Maintains | 8 days ago |
Inspire Medical Systems IncINSP | 4 | Buy | $55.00 | +31.20% | Maintains | 10 days ago |
Rambus IncRMBS | 4 | Buy | $172.00 | +27.55% | Maintains | 17 days ago |
Repligen CorpRGEN | 6 | Buy | $140.00 | +30.80% | Maintains | a month ago |
Transmedics Group IncTMDX | 3 | Buy | $118.00 | +83.86% | Maintains | a month ago |
Minimed Group IncMMED | 1 | Buy | $20.00 | +78.89% | Initiates Coverage On | a month ago |
West Pharmaceutical Services IncWST | 4 | Buy | $320.00 | +5.82% | Maintains | 3 months ago |
Dexcom IncDXCM | 1 | Hold | $68.00 | +16.10% | Initiates Coverage On | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.